Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 798 for “"PD-1"”.

  1. Changes in peripheral blood PD-1 receptor expression under anti-PD-1 Immune Checkpoint Therapy

    … in autoimmunity and cancer. Programmed Death 1 (PD-1) is one of the most relevant immune checkpoints known and research around it as well as approval of anti-PD-1 monoclonal antibodies has led to a revolution in cancer therapy in the last decade. While trial results and remission rates have been …

    fu-berlin Repository record for Changes in peripheral blood PD-1 receptor expression under anti-PD-1 Immune Checkpoint Therapy (opens in a new tab)

  2. Second generation superagonistic anti-PD-1 antibodies

    … could also be induced by 1st generation anti-PD-1 antibodies that bind close to the membrane with high affinity, or away from the membrane with very low affinity. We have combined the apparently advantageous features of both sets of antibodies into a single 2nd generation anti-PD-1 antibody …

    oxford Repository record for Second generation superagonistic anti-PD-1 antibodies (opens in a new tab)

  3. PD-1/PD-L1 immunotherapy blockade in solid tumors: role of PD-1/PD-L1 in cancer disease progression

    … concept behind cancer and focuses on the use of PD-1 in tumors as a way of immune evasion as well as the use of PD-1/PD-L1 blockade as an innovative target for immunotherapy. Cancer arises from mutagenic events resulting in the presence of abnormal cells and uncontrollable cell proliferation. It …

    bu Repository record for PD-1/PD-L1 immunotherapy blockade in solid tumors: role of PD-1/PD-L1 in cancer disease progression (opens in a new tab)

  4. FLIPPING THE SWITCH ON PD-1 IN MYELOMA

    … to tumor-induced anergy. To overcome this, PD-1 blockade which has been used extensively clinically with impressive clinical results with many solid tumors, represents an approach to prevent tolerance and enhance T cell activity. As a single agent, PD-1 blockade has not shown any clinical …

    jhu Repository record for FLIPPING THE SWITCH ON PD-1 IN MYELOMA (opens in a new tab)

  5. cJun Overexpression Sensitizes CAR-T Cells to PD-1 Axis Blockade by Preserving an Intratumoral PD-1⁺ Tcf1⁺ Stem-Like Reservoir

    … Additionally, this thesis focuses on the role PD-1⁺ Tcf1⁺ stem-like T cells play in mediating responses to immune checkpoint blockade and examines whether CAR-T cells are capable of forming and maintaining this critical stem-like reservoir in the solid tumor microenvironment (TME). This work …

    washington Repository record for cJun Overexpression Sensitizes CAR-T Cells to PD-1 Axis Blockade by Preserving an Intratumoral PD-1⁺ Tcf1⁺ Stem-Like Reservoir (opens in a new tab)

  6. The Role of the PD-1 Immunoreceptor in Pregnancy

    … We propose that the CD28 family immune receptor, PD-1, functions during pregnancy to control maternal immune reactions. PD-1 is expressed on T lymphocytes and following interaction with its ligand, B7-H1, prevents T cell activation. B7-H1 is expressed in the human placenta throughout gestation, …

    ku Repository record for The Role of the PD-1 Immunoreceptor in Pregnancy (opens in a new tab)

  7. Computational Design of Hyperstable, De Novo Miniproteins Targeting PD-1

    … cell receptor, programmed cell death protein 1 (PD-1). Expressed on activated T cells, PD-1 inhibits T cell function and proliferation to prevent an excessive immune response. Tumor cells often take advantage of this pathway by over-expressing one of the ligands of PD-1, PD-L1 or PD-L2, to evade …

    washington Repository record for Computational Design of Hyperstable, De Novo Miniproteins Targeting PD-1 (opens in a new tab)

  8. Modulation of the PD-1 pathway by inhibitory antibody superagonists

    … the T cell inhibitory cell surface receptor PD-1 and test if this approach can attenuate the immune response. Using in vitro assays of lymphocyte activation and a mouse model expressing human PD-1, this study characterises a series of anti-PD-1 antibodies and shows how patterns of inhibitory …

    oxford Repository record for Modulation of the PD-1 pathway by inhibitory antibody superagonists (opens in a new tab)

  9. Expression of programmed death-1 (PD-1) and PD-1 ligands in human and murine tissue and their role in immunological tolerance: genetic, immunologic and immunohistochemical analysis of the PD-1/PD-L1 pathway in human systemic lupus erythematosus

    … of T cell function. Programmed death-1 (PD-1) is an inhibitory lymphocyte receptor that has recently emerged as a key player in induction and maintenance of tolerance. Compared to other B7 receptors, PD-1 has a broader role in regulation of immune responses considering its expression on …

    greece Repository record for Expression of programmed death-1 (PD-1) and PD-1 ligands in human and murine tissue and their role in immunological tolerance: genetic, immunologic and immunohistochemical analysis of the PD-1/PD-L1 pathway in human systemic lupus erythematosus (opens in a new tab)

  10. Expression of programmed death-1 (PD-1) and PD-1 ligands in rheumatoid arthritis, in human and murine tissue, and their role in immunological tolerance

    … of T cell function.Programmed death-1 (PD-1) is an inhibitory lymphocyte receptor that has recently emerged as a key playerin induction and maintenance of tolerance.Rheumatoid arthritis (RA) is a chronic inflammatory disease of joints and extra-articular tissues, whichcauses severe …

    greece Repository record for Expression of programmed death-1 (PD-1) and PD-1 ligands in rheumatoid arthritis, in human and murine tissue, and their role in immunological tolerance (opens in a new tab)

  11. Characterizing the Development of T cell Exhaustion Independent of PD-1

    … function of these cells. Programmed death-1 (PD-1), T cell immunoglobulin mucin-3 (TIM-3), cytotoxic T lymphocyte associated protein 4 (CTLA-4), and several other molecules have important functions in driving and maintaining T cell exhaustion. Research has furthered our understanding of how …

    jhu Repository record for Characterizing the Development of T cell Exhaustion Independent of PD-1 (opens in a new tab)

  12. Micrornas Associated With Melanoma Inflammation and Response to Pd-1 Inhibition

    … investigation of these microRNAs in a cohort of PD-1 inhibitor treated melanoma patients identified a survival benefit in patients whose melanomas had high expression of miR-100-5p and miR-125b-5p. These findings indicate that microRNA regulation of gene expression in melanoma is relevant to …

    uthsc Repository record for Micrornas Associated With Melanoma Inflammation and Response to Pd-1 Inhibition (opens in a new tab)

  13. Loss of Ptdss1 in tumor cells improves anti-PD-1 therapy

    … we identified PTDSS1 as a target to improve anti-PD-1 therapy. Depletion of PTDSS1 in tumor cells increased expression of IFNγ-regulated genes, including B2m, Cxcl9, Cxcl10, and Stat1. Loss of PTDSS1 in tumor cells also led to increased expression of MHC-I, which was associated with increased …

    uthsc Repository record for Loss of Ptdss1 in tumor cells improves anti-PD-1 therapy (opens in a new tab)

  14. Expression von PD-L1 und PD-1 im nicht-kleinzelligen Lungenkarzinom

    … beschäftigt sich mit der Expression der Proteine PD-L1 (B7-H1,<br>CD274) und PD-1 (CD279) auf Tumorzellen und TIL des NSCLC. Tumorseitig soll PD-L1 den auf<br>infiltrierenden Lymphozyten exprimierten Rezeptor PD-1 inhibieren und dadurch zu einer Anergie<br>des Immunsystems und in Folge dessen zu …

    freiburg-diss Repository record for Expression von PD-L1 und PD-1 im nicht-kleinzelligen Lungenkarzinom (opens in a new tab)

  15. Αποτελεσματικότητα και ασφάλεια αναστολέων PD-1 στο μεταστατικό μελάνωμα, συστηματική ανασκόπηση

    Εισαγωγή: Οι αναστολείς των υποδοχέων PD-1 έχουν φέρει επανάσταση στη θεραπεία του μελανώματος και χρησιμοποιούνται ως θεραπεία πρώτης γραμμής σε ασθενείς με προχωρημένο/μεταστατικό μελάνωμα. Αυτά τα μονοκλωνικά αντισώματα ενισχύουν την αντικαρκινική ανοσολογική απόκριση των Τ-κυττάρων, οδηγώντας …

    athens Repository record for Αποτελεσματικότητα και ασφάλεια αναστολέων PD-1 στο μεταστατικό μελάνωμα, συστηματική ανασκόπηση (opens in a new tab)

  16. The role of PD-1 in macrophage polarization and fate commitment

    Background: PD-1 is a checkpoint receptor that has been shown to inactivate T cells through SHP-2 recruitment. However, tumor bearing mice with conditional deletion of SHP-2 in T cells did not demonstrate any differences in tumor progression compared to wild type mice. Both PD-1 and SHP-2 are also …

    greece Repository record for The role of PD-1 in macrophage polarization and fate commitment (opens in a new tab)

Page 1 of 40